Breakdown of Hepatitis C Genotype Distribution Around the World
NOVEMBER 28, 2016
People who inject drugs (PWID) are more likely to develop hepatitis C. The Centers for Disease Control and Prevention (CDC) points out that the virus can survive on equipment, such as needles, for up to three weeks. However, some of the different hepatitis C genotypes are more prominent in certain areas than others. A report published in the Journal of Hepatology uncovered the distribution of hepatitis C genotypes by continent in PWID.
Geert Robaeys, MD, PhD, and Rob Bielen, MD, from Ziekenhuis Oost-Limburg in Belgium, and colleagues, reviewed 48 studies from 48 countries. The data was collected from 1995 to 2005 from PWID. There are at least six different hepatitis C genotypes and over 50 subtypes, according to the CDC. The most prevalent genotypes were specified by continent:
- Globally: genotype 1
- Africa: genotypes 1a and 4
- Asia: genotypes 2 and 6
- Australia: genotypes 1 and 3
- Europe: genotypes 1, 3, and 4
- North America: genotypes 1 and 3
- South America: genotypes 1 and 3
More specific findings revealed that although genotype 4 is known as the “African genotype,” there is little data on PWID – but the studies still found that it’s prominent in Africa. In addition, a few of the studies concluded that genotype 2 is highly prevalent in Japan.
Further discussion suggested that opiate drug trafficking routes from India to Afghanistan into Europe, and then onward to North and South America and Australia, could explain the spread of genotype 3.
“Our study confirms a high prevalence of genotype 3 in South Asia, fading via Europe to the rest of the world,” the team wrote. Moreover, the prevalence of genotype 3 is globally higher in the PWID group, supporting this hypothesis.”
Genotype 6 was primarily found in Vietnam and China. Less than 2% of hepatitis C cases in the United States involve genotype 5 or 6, according to Hepatitis C Online from the University of Washington.
This data provides insight of hepatitis C genotype distribution in PWID; therefore, cases may vary among those who do not inject drugs.
Should Generic DAAs Be More Widely Imported?
Multi-Genotype Hepatitis C Test Drug Successful in Phase 3 Trials
Tennessee Prison Officials Request Millions to Fight Hepatitis C